We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
After a Solid Q3, Can M&A ETF Soar in Q4?
It was a great Q3 for mergers and acquisitions (M&A) that were on hold amid the peak of coronavirus-led lockdowns. A flurry of deals in September led to a record Q3 with more than $1 trillion worth transactions globally, according to Refinitiv data, as quoted on Reuters.
M&A activity skyrocketed 80% sequentially in Q3. These include the announcements of Nvidia-Arm deal for $40 billion, the Microsoft-ZeniMax Media deal for $7.5 billion, the Gilead Sciences–Immunomedics deal for about $21 billion, the Verizon Communications-America Movil deal for about $6.9 billion and ByteDance’s selection of Oracle as its technology partner in the United States.
While the sky-high valuation of stocks may slow down the deal-making momentum in Q4, rock-bottom interest rate levels should keep favoring the space. IQ Merger Arbitrage ETF (MNA - Free Report) has amassed about $714.8 million in assets so far. The underlying IQ Merger Arbitrage Index seeks to identify opportunities in companies involved in announced mergers, acquisitions and other buyout-related transactions. MNA has gained about 7.4% in the past three months.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>